The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amoclav 250mg/125mg Film-coated Tablets

250 mg/125 milligram(s) Film-coated tablet

Rowex LtdPA0711/162/002

Main Information

Trade NameAmoclav 250mg/125mg Film-coated Tablets
Active SubstancesAmoxicillin trihydrate
potassium clavulanate
Strength250 mg/125 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderRowex Ltd
Licence NumberPA0711/162/002

Group Information

ATC CodeJ01CR Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02 amoxicillin and enzyme inhibitor

Status

Authorised/WithdrawnAuthorised
Licence Issued21/03/2003
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0037-074-003
Interchangeable List DocumentPDF of Interchangeable List
« Back